Medical News Podcast

Corinne Young, MSN, FNP‑C, FCCP, and Jessica Glennie, CNP, share insights on identifying, diagnosing, treating, and setting goals of care for patients with ILDs as advanced practice providers in a variety of practice settings (Part 1 of 2).

Drs. Callahan and Yuan share their insights into HER2‑low breast cancer, including the evolving definitions and testing approaches, and exploring how these results can impact treatment.

Join Drs. Yuan and Callahan as they continue their discussion on HER2+ testing by reviewing our current understanding of HER2+ low and how it differs from HER2+ and HER2 negative. They explore the role of neoadjuvant therapy in HER2+ patients, post-operative phenotype shifts, and the need for HER2+ testing after surgery. They share cases from their practices where these issues arose and discuss ho...

Which modifiable factors can cut risk of dementia in half? Find out about this and more in today's PeerDirect Medical News Podcast.

Drs. Yuan and Callahan discuss HER2 testing in breast cancer. They will explore the clinical relevance and need for testing, and discuss testing methods, evolving testing guidelines, and interpretation of results.

Can a twice-yearly shot provide 100% protection against HIV? Find out about this and more in today's PeerDirect Medical News Podcast.

Drs. Vela and Adegunsoye explore the intersections of patient education, community engagement, and healthcare policies, particularly in addressing the needs of underrepresented racial groups. Monica emphasizes the value of long-term patient-physician relationships in primary care, the necessity of interrupting physician biases, and the importance of systemic changes to facilitate more comprehensiv...

Drs. Vela and Adegunsoye delve into the racial disparities in the diagnosis and progression of pulmonary fibrosis, particularly within the black population. They discuss the role of environmental and occupational exposures, and the impact of cultural and autoimmune factors on the disease's prevalence in black communities. Dr. Adegunsoye emphasizes that black individuals are at a higher risk for au...

Drs. Vela and Adegunsoye share their insights into racial disparities in pulmonary fibrosis, including the impact of characterizing groups based on skin color or race, the concept of cultural humility, and best practices for diagnosing ILD while taking into account these disparities.

How does opioid prescribing in the ED differ between races? Find out about this and more in today's PeerDirect Medical News Podcast.

Drs. Gina Woods and Susan V. Bukata review surgical care, including joint replacement and spine surgery, in patients with osteoporosis. They discuss the planning and operative techniques that help improve outcomes in these patients.

Drs. Susan V. Bukata and Gina Woods discuss the perioperative care of patients with osteoporotic fractures and those with osteoporosis undergoing elective surgery.

Learn about OXO-001, a non-hormonal drug that increases pregnancy rates in women undergoing IVF or ICSI by enhancing embryo implantation. Also in this episode: patients with type 2 diabetes taking GLP-1 receptor agonists have a lower risk of certain obesity-associated cancers compared to those on insulin, though no significant reduction compared to metformin. Finally, the third story highlights re...

Dr. Susan V. Bukata and Freda B. Hannafon, NP‑C, discuss the role of nurse practitioners and physician assistants in the care of patients with postmenopausal osteoporosis, including diagnosis, management, and collaboration with endocrinologists and orthopedic surgeons.

Drs. Mattingly and McIntyre continue their discussion about their insights into the role of emerging and novel mechanisms of action for potential treatments of schizophrenia, particularly those addressing the negative and cognitive symptoms.

Drs. Roger McIntyre and Greg Mattingly share their insights into the role of emerging and novel mechanisms of action for potential treatments of schizophrenia, particularly those addressing the negative and cognitive symptoms.

In the second part of this series, Drs. Henry A. Nasrallah and Dawn Velligan continue sharing their insights into the importance of assessing and screening for cognitive impairment in patients with schizophrenia. They discuss why testing for cognitive impairment in standard clinical practice isn’t more widespread, the barriers clinicians face in testing, and the misconception that testing for cogn...

Drs. Dawn Velligan and Henry A. Nasrallah share their insights into the importance of assessing and screening for cognitive impairment in patients with schizophrenia. They discuss why testing for cognitive impairment in standard clinical practice isn’t more widespread, the barriers clinicians face in testing, and the misconception that testing for cognitive impairment is prohibitive due to the res...

Dr. Gus Alva and Ms. Sheena Patel, PA-C, continue their conversation, sharing insights into the three symptom domains of schizophrenia: positive, negative, and cognitive impairment. They discuss how each of these symptom domains could present in the outpatient clinical practice, with particular focus on negative symptoms and cognitive impairment.

Can a new drug slow the progression of Alzheimer's disease? Find out about this and more in today's PeerDirect Medical News Podcast.

Ms. Sheena Patel, PA-C, and Dr. Gus Alva share their insights into the three symptom domains of schizophrenia: positive, negative, and cognitive impairment, and how each of these symptom domains could present in the outpatient clinical practice. In particular, they discuss the less obvious domains: negative symptoms and cognitive impairment.

Can islet cell transplant eliminate the need for insulin in patients with type 1 diabetes? Find out about this and more in today's PeerDirect Medical News Podcast.

Can the use of hearing aids slow down cognitive decline? Find out about this and more in today's PeerDirect Medical News Podcast.

Drs. Claudine Isaacs and Filipa Lynce conclude their discussion on the highlights of ASCO 2024 Annual Meeting, with a focus on HER2+ breast cancer. They discussed results from the Destiny Breast 07 trial, highlighting the efficacy of TDXD alone and in combination with pertuzumab in first-line treatment of HER2-positive breast cancer. The study showed high overall response rates and promising progr...

Drs. Claudine Isaacs and Filipa Lynce continue their discussion on the highlights of ASCO 2024 Annual Meeting, with a focus on HER2+ breast cancer. In part two of the discussion, the focus is on two studies pertaining to HER2-positive breast cancer. The first study, the GBCRG-M06 Emerald Study compared the effectiveness and toxicity of eribulin mesylate versus a taxane (with trastuzumab and pertuz...